114 completed, 22 unknown, 16 recruiting, 11 not yet recruiting. 58 Phase 2, 57 Phase 1, 32 Not applicable, 26 Phase 3, 26 Phase 4.
Follow Capsules: new trials by email Literature Review of Capsules trials Research Report on Capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nicotinamide Riboside Supplementation in Chronic Kidney Disease Nicotinamide Riboside (NR), Matched Placebo (Capsules) - Chronic Kidney Disease | Phase 2 | Not yet recruiting | University of California, San Diego | 30 | 2027-01-15 | 2026-11-12 |
| Verapamil In Preclinical Type 1 Diabetes Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release, Placebo, blood sampling - Type 1 Diabetes | Phase 2 / Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 50 | 2027-01-01 | 2026-10-22 |
| LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response Lithium orotate, Matched Placebo (Capsules) - Alzheimer s Disease | Phase 1 / Phase 2 | Not yet recruiting | Johns Hopkins University | 40 | 2026-12-01 | 2026-10-07 |
| Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis Oral Decitabine and Tetrahydrouridine, Matched Placebo (Capsules) - Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 2 | Not yet recruiting | Clinical Hub for Interventional Research (CHOIR) | 80 | 2026-12-01 | 2026-11-04 |
| Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE) Microbiota transplant therapy (MTT) capsules, Placebo capsule - Hepatic Encephalopathy, Cirrhosis | Phase 2 | Not yet recruiting | VA Office of Research and Development | 162 | 2026-10-30 | 2026-04-14 |
| Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) ATV-1601, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease | Phase 1 / Phase 2 | Recruiting | Atavistik Bio, Inc | 100 | 2026-07-27 | 2026-11-06 |
| Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions SKI-O-703 API in Capsules, SKI-O-703 Formulated Granules in Capsules - Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP) | Phase 1 | Active not recruiting | Oscotec Inc. | 48 | 2026-07-10 | 2026-09-01 |
| Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial Fecal Microbiota Transplantation (FMT) Capsules, Placebo capsules - Heart Failure With Preserved Ejection Fraction (HFPEF), Chronic Heart Failure | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Air Force Medicial University | 50 | 2026-06-01 | 2026-06-05 |
| Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency LUM-201, Matched Placebo (Capsules) - Growth Hormone Deficiency (GHD) | Phase 3 | Recruiting | Lumos Pharma | 150 | 2026-05-20 | 2026-10-19 |
| Can Astaxanthin Help Manage Asthma in POlluted Areas? Astaxanthin Oral Capsule, Matched Placebo (Capsules) - Asthma (Diagnosis), Airway Inflammation | Not applicable | Recruiting | Middlesex University | 25 | 2026-05-15 | 2026-04-02 |
| Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance Comparative Acute Effects of Caffeine Delivery Forms (Capsule, Chewing Gum, Mouth Rinse) on Aerobic Capacity and Wingate Anaerobic Performance Outcomes in Recreational Male Athletes: A Randomized Coun - Exercise Performance, Physical Performance | Not applicable | Completed | University of Gaziantep | 14 | 2026-04-20 | 2026-08-20 |
| Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder Lumateperone (ITI-007), Placebo Tablet or Capsule - Stuttering, Adult | Phase 2 | Recruiting | CSTrials Inc. | 24 | 2026-04-18 | 2026-07-29 |
| Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb) TRD205 Tablets, oral; 400 mg initial dose, then 200 mg q12h for 3 doses; total 4 doses, TRD205 Tablets, oral; 800 mg initial dose, then 400 mg q12h; total 4 doses, TRD205 Tablets, oral; 1200 mg initial dose, then 600 mg q12h; total 4 doses - Postoperative Analgesia After Unilateral Hip Arthroplasty | Phase 2 | Recruiting | Beijing Tide Pharmaceutical Co., Ltd | 200 | 2026-03-18 | 2026-04-22 |
| Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia Minoxidil 5 % Topical Spray, minoxidil, Placebo Spray - Androgenic Alopecia | Phase 3 | Not yet recruiting | Sheikh Zayed Federal Postgraduate Medical Institute | 200 | 2025-12-20 | 2025-12-10 |
| Study of DONQ52 in Active Celiac Disease Placebo DONQ52, Simulated Inadvertent Gluten Exposure (SIGE) capsule, DONQ52 - Celiac Disease | Phase 2 | Recruiting | Chugai Pharmaceutical | 92 | 2025-12-16 | 2026-08-14 |
| Omega-3-Based Nutraceutical Supplementation as Adjunctive Therapy in Adults With Otitis Media With Effusion: A Multicenter, Double-Blind, Randomized Placebo-Controlled Trial Omega-3-based nutraceutical combination (Otoair Flogo), Bilastine 20 mg, Placebo Tablet or Capsule - Otits Media With Effusion | Phase 4 | Completed | Isola Tiberina - Gemelli Isola Hospital, Rome, Italy | 501 | 2025-10-01 | 2026-07-23 |
| Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome Quercetin, Alpha Lipoic Acid 600 MG Oral Tablet, MetFORMIN 500 Mg Oral Tablet - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Phase 2 | Recruiting | Al-Mustansiriyah University | 150 | 2025-09-20 | 2025-09-19 |
| Investigating the Effect of Dronabinol on Post-surgical Pain Dronabinol 5mg Cap, Non-active comparator - Knee Replacement, Arthropathy of Knee | Early Phase 1 | Withdrawn | New York State Psychiatric Institute | 2025-09-01 | 2023-11-13 | |
| Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea Everolimus, Mycophenolate mofetil Tablet/Capsule - Heart Transplant | Phase 4 | Not yet recruiting | Chong Kun Dang Pharmaceutical | 140 | 2025-08-14 | 2025-04-24 |
| Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions. Ingavirin forte, capsules, 90 mg + 20 mg, Ingavirin, capsules, 90 mg - Influenza, Acute Respiratory Viral Infections | Phase 1 | Recruiting | Valenta Pharm JSC | 36 | 2025-07-11 | 2026-06-12 |
Showing 20 of 187. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (5) · Hypersensitivity (4) · Inflammation (4) · Pain, Postoperative (4) · Peanut Hypersensitivity (4) · Anxiety Disorders (3) · COVID-19 (3) · Cardiovascular Diseases (3) · Diabetes Mellitus, Type 1 (3) · Diabetes Mellitus, Type 2 (3) · Fibrosis (3) · Iron Deficiencies (3) · Liver Diseases (3) · Marijuana Abuse (3) · Neoplasms (3)
Actavis Inc. (5) · Aimmune Therapeutics, Inc. (4) · Chong Kun Dang Pharmaceutical (4) · AstraZeneca (3) · Washington University School of Medicine (3) · Abbott (2) · Alexandria University (2) · Assistance Publique - Hôpitaux de Paris (2) · Assiut University (2) · Cairo University (2) · Eli Lilly and Company (2) · Fudan University (2) · Galderma R&D (2) · Genentech, Inc. (2) · GlaxoSmithKline (2)
United States (74) · United Kingdom (19) · Canada (17) · South Korea (14) · China (12) · France (12) · Germany (12) · Egypt (10) · Italy (9) · Spain (9) · Australia (8) · India (8) · Netherlands (8) · Belgium (7) · Poland (7)
Craig A Buchman, MD, FACS (2) · Daniel V. Freeland, DO (2) · Gaetano Morelli, M.D. (2) · James P. Doherty, DO (2) · Alan S. Marion, MD, PhD (1) · Alfonso Galderisi, Phd (1) · Andre Crouch, MD (1) · Andriy Yabluchanskiy, MD, PhD (1) · Ann Childress, MD (1) · Anthony Bier, MD (1)
PMID 34389504, PMID 34320250, PMID 36915184, PMID 36971690, PMID 41342306, PMID 11756098, PMID 12072644, PMID 17011944, PMID 17102958, PMID 19923168, PMID 20393175, PMID 20402746, PMID 20620737, PMID 21055801, PMID 21079055, PMID 22212857, PMID 22266271, PMID 22387529, PMID 22431798, PMID 22740509, PMID 22795280, PMID 23018163, PMID 23252527, PMID 23391616, PMID 23787544, PMID 23954314, PMID 23974954, PMID 2466358, PMID 24840045, PMID 24988179, PMID 25245629, PMID 25391138, PMID 25467588, PMID 25530364, PMID 25728587, PMID 25830118, PMID 26935876, PMID 27032509, PMID 27418629, PMID 27867688, PMID 27908918, PMID 28456631, PMID 28738099, PMID 28891138, PMID 29049117, PMID 29138921, PMID 29621129, PMID 29881409, PMID 30025991, PMID 30180998
2018 (3), 2023 (2), 1IK2CX000946-01 (1), 2005 (1), 2015 (1), 2019 (1), 2025 (1), K01DK147652 (1), R01AA029398 (1), R21AT002073 (1), ZIAHD000641-23 (1)